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Abstract
OBJECTIVE—To evaluate the relationship between gestational age (GA) and induction of labor
(IOL) and the rate of cesarean delivery (CD) in women with mild gestational diabetes (GDM).
STUDY DESIGN—Secondary analysis of data from a multi-center RCT of mild GDM treatment.
CD rate of women delivering at term (≥ 37 weeks) was evaluated using two complementary
approaches: 1) IOL vs. spontaneous labor: women induced at each GA compared with those who
spontaneously labored at the same GA, and 2) IOL vs. expectant management: women delivered
after IOL at each GA compared with those delivering after spontaneous labor at the same GA or
subsequently after spontaneous or induced labor (outcome at each week compared with expectant
management at that week). Logistic regression adjusted for potential confounders.
RESULTS—The overall CD rate was 13%. When compared to 39 weeks (either IOL or
spontaneous labor) as the referent, there was no significant difference in the CD rate in women
delivered at 37, 38, or 40 weeks. However, IOL was associated with a 3-fold increase in CD rate
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at 41 weeks and beyond as compared with IOL at 39 weeks. Similarly, there was a 3-fold increase
in CD rate in women who were induced when compared to those managed expectantly at 40
completed weeks.
CONCLUSIONS—Induction of labor in women with mild gestational diabetes mellitus (GDM)
does not increase the rate of cesarean delivery prior to 40 weeks gestation.
Keywords
cesarean delivery; gestational diabetes; induction of labor
INTRODUCTION
The cesarean delivery rate has continued to rise to a recent high of 32%, increasing more
than 50% in the last decade1. Similarly, the rates of IOL have increased, now affecting 23%
of all births1. Previous observational studies have suggested that induction predisposes
women to CD. Specifically, when comparing women undergoing IOL to those experiencing
spontaneous labor, an increased rate of CD has been observed.2, 3 However, when compared
to expectant management, elective induction of labor at or beyond 41 weeks is associated
with a decreased rate of cesarean section.4, 5 A recent Cochrane metanalysis suggests that
elective induction of labor at term, when compared with expectant management, is
associated with a decreased rate of cesarean section as well as other adverse perinatal
outcomes.6
The discrepancies in the findings of these are partially explained by differences in
comparison groups. While initial studies compared induced with spontaneous labor, more
recent studies have used an expectant management comparison group, which includes
patients who spontaneously delivered as well as those who were induced at later gestational
ages. This comparison is more appropriate in clinical decision-making since expectant
management, not spontaneous labor, at a particular gestational age is the only alternative.
The MFMU Network randomized controlled trial (RCT) for the treatment of mild GDM
demonstrated that treatment of mild gestational diabetes (GDM) is associated with a lower
rate of cesarean delivery (26.9% vs. 33.8%, p = 0.02).7 This reduced risk was apparent even
after excluding cesarean indications such as malpresentation, placenta previa,
oligohydramnios, and previous cesarean. A high proportion (27%) of patients underwent
induction in each group.
The primary aim of this study was to compare the rate of CD by gestational age and by IOL
vs. expectant management in women with GDM. As a secondary aim, we compared
perinatal outcomes among the study groups.
METHODS AND MATERIALS
We performed a secondary analysis of a multicenter randomized trial evaluating the effect of
treatment in women with mild GDM.7 In the original trial, women at 24–30 weeks gestation
with blood glucose levels of 135–199 mg/dL following a 50 gram glucose loading test were
invited to enroll. Eligible women underwent a blinded 3-hour 100 gram oral glucose
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tolerance test. Mild GDM was defined as fasting glucose levels of less than 95 mg/dL and at
least two abnormal timed measurements (>180 mg/dL at 1 hour, >155 mg/dL at 2 hours, and
>140 mg/dL at 3 hours). Women with mild GDM were randomized to usual prenatal care or
treatment with dietary modifications, glucose monitoring, and insulin, if indicated. Providers
and patients were blinded to GDM diagnosis in the standard care group. The original study
was approved by the institutional review boards of all participating clinical centers, and all
enrolled women gave informed consent.
Women in both the treatment and standard care group were included in this secondary
analysis if they delivered at term (≥37 weeks), underwent induced or spontaneous labor, and
had cephalic presentations. Patients were excluded from analysis if they had an elective
scheduled CD, had one or more previous CDs, had a non-cephalic presentation, or a major
fetal anomaly. The primary outcome was CD. The CD rate was assessed by two approaches:
1) patients delivered at a specific GA (in completed weeks) and type of labor were compared
to those who delivered at 39 weeks; 2) patients undergoing IOL at a specific GA were
compared with those “expectantly managed”, which included patients who delivered at the
same GA following spontaneous labor and patients who delivered at subsequent GA
following spontaneous or induced labor. We examined several secondary outcomes. First,
the composite perinatal outcome, included any one of the following: hypoglycemia,
hyperbilirubinemia, RDS, and birth trauma which have been associated with GDM. We also
assessed the frequency of admission of the infant to the neonatal intensive care unit (NICU),
of birthweight >4000g, and of large-for-gestational age (LGA) infants, defined as
birthweight > 90th percentile.8
Categorical variables were analyzed using the chi square or Fisher’s exact test. Continuous
variables were analyzed using the Wilcoxon rank sum or the Kruskal-Wallis test. Study
outcomes by completed GA week were calculated by type of labor for the two comparison
methods. Multivariable logistic regression analysis was used to adjust for potential
confounders for most outcomes including maternal age, race/ethnicity, pre-pregnancy body
mass index (BMI), parity, smoking status, Cesarean delivery (for neonatal outcomes), infant
sex (for neonatal outcomes), timing of dating ultrasound (trimester), SGA, and treatment
group. No adjustments were made for the outcome of NICU admissions due to to small
numbers. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated
relative to the IOL group at 39 weeks in method 1 and the expectant management group at
each GA in method 2.
Statistical analyses were conducted using SAS software (SAS Institute, Cary, NC). A
nominal two-sided p-value < 0.05 was considered for statistical significance with no
adjustments made for multiple comparisons.
RESULTS
Of the 958 women enrolled in the original RCT, 679 met inclusion and exclusion criteria for
this secondary analysis. Baseline characteristics of the study population are shown in Table
I. Reflective of the original study population, over half of the women were Hispanic, and the
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mean BMI at enrollment was approximately 30 (± 5.0) kg/m2. Race/ethnicity and GDM
screen results differed by completed GA at delivery.
The overall rate of CD was 13%. The indications for cesarean section were: failed induction
(69.3%), non-reassuring fetal tracing (26.1%), cord prolapse (3.4%), and chorioamnionitis
(1.2%). The crude and adjusted results for CD are presented in Table II. Of note, the results
were adjusted for maternal age, ethnicity, BMI, parity, smoking, timing of dating ultrasound,
SGA status, and assigned control vs. treatment group. The CD incidence increased from
10.3% to 22.7% as gestational age at delivery increased from 37 to 41 completed weeks.
This pattern was primarily restricted to the IOL group. When comparing the rate of CD at
each GA with 39 completed weeks as the referent (method 1), there was no significant
difference in the adjusted CD delivery rate at 37, 38, and 40 completed weeks. However, at
41 weeks, IOL was associated with a 3-fold increase in CD as compared with IOL at 39
weeks. Likewise, when comparing women undergoing IOL vs. those expectantly managed
(method 2), IOL was not associated with an increased adjusted rate of CD at 37, 38, or 39
completed weeks. At 40 completed weeks, IOL was associated with a 3-fold increased in
CD rate. There was a similar increase in CD rate at 41 completed weeks and greater, but this
association was not statistically significant. The CD risks when stratified by treatment group
are shown in Tables IIIA and IIIB. In the treated group, based on small numbers, there was a
trend toward a reduction in CD risk associated with IOL prior to 39 weeks the OR (95% CI)
with IOL when compared to those expectantly managed was 1.97 (0.39, 9.95) at 40 and
3.94(0.10, 158.6) at ≥41 weeks (Table IIIB). However, these comparisons were not
statistically significant. In the standard care group, the OR (95% CI) for IOL compared to
the expectant management group was 3.07 (1.05, 8.96) at 40 weeks and 3.76 (0.69, 20.58) at
≥41 weeks; there were no increases at 37, 38 or 39 weeks (Table IIIA).
The frequency and adjusted odds of the composite perinatal outcome were not different in
the IOL group when compared to either the spontaneous labor (method 1) or expectant
management group (method 2) at all GAs (Table IV). There were no cases of stillbirth or
neonatal deaths in this study. Furthermore, there were no significant differences in the
unadjusted frequency of NICU admissions between the groups with the exception of an
increase in NICU admissions in the IOL group at ≥ 41 weeks (there were no NICU
admissions in the ≥ 41 week expectant management group; data not shown). There was a
significant increase in the frequency of infants with birthweight > 4000g at ≥ 41 weeks when
compared to 39 weeks (OR of 2.83 with 95% CI of 1.31–6.14) in all deliveries (data not
shown). However, there were no significant differences in the frequency of either infants
with birthweight > 4000g or LGA neonates in the IOL vs. expectant management groups at
all gestational ages (data not shown).
COMMENT
We found an increasing trend in cesarean delivery risk with increasing gestational age at
term. When compared to expectant management, IOL in patients with mild GDM was not
associated with an increase in CD rate until 40 weeks. When stratified for treatment group
(standard care and treated groups), results (limited by numbers), were similar to the overall
findings; the increase in CD risk from 40 weeks appeared to be more prominent among
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those who were not treated. Furthermore, we found no significant differences in perinatal
outcomes between patients undergoing IOL compared to either those spontaneously laboring
or those expectantly managed. No significant differences were also observed for NICU
admissions, birthweight > 4000, or LGA neonates.
A recent study indicates that IOL at 39 in women with GDM confers a decrease in perinatal
mortality.9 Our results are mostly consistent with a previous cohort study of term deliveries
that showed no difference in CD rate when IOL was compared to expectant management at
all gestational ages. Similarly, a randomized controlled trial by Boulvain and colleagues
showed no increase in CD rate in non-diabetic women undergoing IOL with suspected fetal
macrosomia.10
Our findings are in line with metanalyses that showed no increase in the CD rate in women
undergoing elective IOL at term.5, 6 In our study, there were no differences in CD rates in
women undergoing IOL vs. expectant management prior to 40 weeks. However, IOL was
associated with an increase in CD rate from 40 weeks. As the population in the current study
was restricted to women with mild GDM and included women undergoing both elective and
indicated IOL, our findings could potentially be attributed to the higher risk of macrosomia,
labor dystocia, and fetal heart rate abnormalities in gestational diabetics leading to higher
CD rate with advancing gestation.
Previous studies have differed in the composition of the expectant management group. For
example, Caughey et al. defined the expectant management group as women delivering,
after either spontaneous or induced labor, during the week following the induction group.11
This approach may favor the induction group because it excludes women who
spontaneously labor in the same week from the expectant management group. In contrast,
Glantz included women who delivered following spontaneous labor the same week as the
induction group in the expectant management group.12 In contrast to the current study, that
analysis demonstrated a small but significant increased risk of CD associated with labor
induction.12 We chose to define the expectant management group as women who delivered
at the same GA following spontaneous labor and patients who delivered at subsequent GA
following spontaneous or induced labor. These differences may account for some of the
variations in findings among these studies. Additionally, given the limitations of the
precision of dating, some of these differences may be affected by variability in the
assignment of gestational age.
Although we simulate IOL vs. expectant management, prospective management regarding
timing of delivery was not a focus of the primary trial. Therefore, this secondary analysis
does not fully capture prospective management intent. Additionally, while adjustment for
confounders such as parity did not alter the results, we do not have data on other factors,
such as cervical status, that may affect these findings. We also did not take into account the
type of gestational diabetes given that few women required medication. Our population is
made up of only women with mild GDM, limiting the generalizability of findings to all
patients with GDM.
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The overall CD rate in this selected population was relatively low at 13%. The CD rate in
original trial was 30%, and the population selected for the current study excluded women
with scheduled CDs, prior CDs, and non-cephalic presentations. It is not clear how a more
liberal use of CD in this population would affect our findings. Over half of the patients in
this study were Hispanic, reflective of the increased risk of GDM associated with Hispanic
ethnicity. Finally, as this was a retrospective analysis of an existing trial, our sample size
likely did not provide sufficient power to account for all possible differences in comparison
groups.
As gestation progresses, particularly in pregnancies complicated by diabetes or other co-
morbidities, the risks of adverse perinatal outcomes such as stillbirth, fetal heart rate
abnormalities, macrosomia, and labor dystocia increases.13, 14 The current study was limited
in that there were no stillbirths in this group, which is explained by the relatively small
sample size of women with only mild GDM.
Taken together, these data support the hypothesis that a policy of induction prior to 40
weeks in women with GDM may not increase the rate of cesarean delivery. Considered
collectively with the studies associating decreasing adverse pregnancy outcomes with
increasing gestational age, our findings suggest that delivery prior to 40 weeks, perhaps as
early as 38 weeks, may improve CD risk in women with mild GDM. This should be
weighed against the impact on other important perinatal outcomes. Therefore, a large,
randomized controlled trial is warranted to further evaluate the maternal and neonatal risks
and benefits of IOL at term and, thus, to determine the optimal gestational age of delivery in
women with GDM.
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• Induction of labor, compared to expectant management, prior to 40 weeks does
not increase cesarean delivery risk in women with mild gestational diabetes
mellitus (GDM).
• Large randomized controlled trials are warranted to fully evaluate the maternal
and neonatal risks associated with induction of labor and to determine the
optimal gestational age of delivery in women with mild GDM.
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